Browsing by Subject Triple negative breast neoplasms -- Diagnosis
Showing results 1 to 4 of 4
Issue Date | Title | Author(s) |
2018 | Biomarker signature defines a potential therapeutic subclass of triple negative breast cancer | Baldacchino, S.; Bonello, D.; Saliba, C.; Grech, Godfrey |
2015 | Decreased expression of CIP2A and SETBP1 following drug-induced activation of the PP2A complex in triple negative breast cancer cell lines | Saliba, Christian; Gauci, Robert; Baldacchino, Shawn; Grixti, Maria Pia; Scerri, Christian; Grech, Godfrey |
2015 | Differential expression of the protein phosphatase 2 (PP2A) inhibitors following PP2A activation by FTY720 in specific breast cancer cell lines | Baldacchino, Shawn; Saliba, Christian; Gauci, Robert; Grixti, Maria Pia; Wastall, Laura M.; Hughes, Thomas A.; Grech, Godfrey |
2017 | Novel biomarker signature predicts sensitivity to PP2A activators in triple negative breast cancer | Baldacchino, Shawn; Saliba, Christian; Scerri, Christian A.; Grech, Godfrey |